According to the analysis of clinical data, higher levels of YAP1 were statistically significantly associated with higher stages III–IV of CRC, and statistical analysis showed a very strong positive correlation between MALAT1 and YAP1 mRNA levels in CRC tissue specimens from patients (Sun et al. 2019b). This evidence concerns the gene MALAT1 and colorectal carcinoma.